Product NDC: | 0023-9211 |
Proprietary Name: | COMBIGAN |
Non Proprietary Name: | brimonidine tartrate, timolol maleate |
Active Ingredient(s): | 2; 5 mg/mL; mg/mL & nbsp; brimonidine tartrate, timolol maleate |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0023-9211 |
Labeler Name: | Allergan, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021398 |
Marketing Category: | NDA |
Start Marketing Date: | 20071114 |
Package NDC: | 0023-9211-03 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-03) > 2.5 mL in 1 BOTTLE, DROPPER |
NDC Code | 0023-9211-03 |
Proprietary Name | COMBIGAN |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-03) > 2.5 mL in 1 BOTTLE, DROPPER |
Product NDC | 0023-9211 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | brimonidine tartrate, timolol maleate |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20071114 |
Marketing Category Name | NDA |
Labeler Name | Allergan, Inc. |
Substance Name | BRIMONIDINE TARTRATE; TIMOLOL MALEATE |
Strength Number | 2; 5 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC],Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |